by
Brendon Nafziger, DOTmed News Associate Editor | March 28, 2011
Imaging entrepreneur Michael Friebe, Ph.D., is stepping down as managing director of Tomovation GmbH and the Northern and Central Europe business of Alliance Medical GmbH at the end of the month, DOTmed News has learned.
Friebe said he will continue as a consultant for the companies through September. Anthony van de Wal will be responsible for NCE reporting and communication to Alliance Medical, according to a statement from the company. He is finance director for the NCE business, according to his Linkedin page.
Alliance Medical told DOTmed News the new "structure" of the company and its subsidiary was still under development, but that the details would be worked out soon.
Ad Statistics
Times Displayed: 172960
Times Visited: 3141 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Friebe founded Tomovation, an MRI, CT and PET-CT services and investment company in the Rurh region of Germany, in 2003. He joined Warwick, UK-based Alliance Medical when it
bought Tomovation in September 2008.
Friebe currently has a number of irons in the fire: he serves as professor of medical imaging entrepreneurship at Technical University in Munich, Germany. He's also an investment partner with FVW Investments for Your Health, a med tech venture capital firm. And he chairs the advisory board of SurgicEye GmbH, a startup that makes intra-operative SPECT devices.
Alliance is a 22-year-old provider of outsourced diagnostic services in Europe, with offices in Germany, Ireland, Italy, the Netherlands, Spain, Poland and the UK. It also runs a fleet of more than a dozen mobile scanners throughout Europe.
